d-penicillamine , a drug used clinically for the treatment of neonatal hyperbilirubinaemia , was tested for interference with the binding of bilirubin to human serum albumin by three methods : 1 ) the peroxidase technique , investigating the effect of d-penicillamine on the equilibrium concentration of unbound bilirubin in a solution containing a molar excess of albumin ;
C0304925
human serum albumin
C0001924
albumin